A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Clinical trial NCT04825743 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04825743
Sponsor: CeleCor Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

ST-elevation Myocardial Infarction (STEMI)

Start date: 2021-04-24
Primary completion: 2026-05-13
Enrollment: 2463

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.